Joel Lapeze
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Joel Lapeze has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Fadi Farhat
Cardiovascular Surgery Department, Alain Sisteron Institute, Infirmerie Protestante de Lyon , Caluire-et-Cuire
1 shared publication - Guy De Gevigney
Hospices Civils de Lyon
1 shared publication - Olivier Jegaden
Mediclinic Middle East
1 shared publication
Latest Publications
- Open Access
- 29 May 2012
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 7 (1) , 47
Aortic valve stenosis after previous coronary bypass: Transcatheter valve implantation or aortic valve replacement?
We report a prospective comparison between transcatheter valve implantation (TAVI, n = 13) and surgical aortic valve replacement (AVR, n = 10) in patients with severe aortic valve stenosis and previous coronary bypass surgery (CABG). All patients had at least bilateral patent internal thoracic arteries bypass without indication of repeat revascularization. After a similar post-procedure outcome, despite one early death in TAVI group, the 1-year survival was 100% in surgical group and in transfemoral TAVI group, and 73% in transapical TAVI group. When previous CABG is the lone surgical risk factor, indications for a TAVI procedure have to be cautious, specially if transfemoral approach is not possible.
- 29 May 2012
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 7 (1) , 47
Open AccessAortic valve stenosis after previous coronary bypass: Transcatheter valve implantation or aortic valve replacement?
We report a prospective comparison between transcatheter valve implantation (TAVI, n = 13) and surgical aortic valve replacement (AVR, n = 10) in patients with severe aortic valve stenosis and previous coronary bypass surgery (CABG). All patients had at least bilateral patent internal thoracic arteries bypass without indication of repeat revascularization. After a similar post-procedure outcome, despite one early death in TAVI group, the 1-year survival was 100% in surgical group and in transfemoral TAVI group, and 73% in transapical TAVI group. When previous CABG is the lone surgical risk factor, indications for a TAVI procedure have to be cautious, specially if transfemoral approach is not possible.